HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (40) Citing Articles via Google Scholar Google Scholar Articles by Bekeredjian, R. Articles by Shohet, R. V. Search for Related Content PubMed PubMed Citation Articles by Bekeredjian, R. Articles by Shohet, R. V.

Use of ultrasound contrast agents for gene or drug delivery in cardiovascular medicine

Raffi Bekeredjian, MD^*, Paul A. Grayburn, MD, FACC^,* and Ralph V. Shohet, MD^*

^* Department of Internal Medicine, Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas
Baylor University Medical Center, Dallas, Texas

View larger version (18K): [in a new window]   Figure 1 Schematic representation of substance delivery using ultrasound-targeted microbubble destruction. An ultrasound contrast agent with an attached or incorporated bioactive substance is administered into the vasculature and will distribute throughout the capillaries. Ultrasound can then destroy microbubbles in the target region, thus releasing the transported substance into the surrounding tissue.